No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Eisai Korean Launch of Leqembi for Alzheimer’s Disease
On 28 November 2024, each of Eisai and Biogen announced the launch of Leqembi® (lecanemab) in Korea for the treatment of adult patients with mild cognitive impairment due to Alzheimer’s disease (AD) or mild AD dementia (early AD). The product was approved by Korea’s...